IRCT20200405046958N2
Recruiting
Phase 2
Evaluation of the effect of therapeutic plasma exchange in patients with acute respiratory distress syndrome caused by Covid 19 disease
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 42
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patient must be definitive case of Covid\-19 based on positive PCR test.
- •The patient must have clinical and paraclinical criteria for acute respiratory distress syndrome (ARDS)
- •The patient age must be over 15 years
- •There must be the informed consent of the patient or his/her legal guardian
Exclusion Criteria
- •The patient has unstable hemodynamics
- •The patient has a history of previous acute cardiac infarction in the last 3 months
- •The patient has a history of allergies to blood products
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Benchmarking therapeutic plasma exchange for the indications in a tertiary care centre as per the international guidelines.CTRI/2023/12/060962Kasturba Medical College PG thesis grant
Completed
Not Applicable
Study of the effects of therapeutic plasmapheresis in comparison with corticosteroid therapy on the immune system of MS patientsMultiple sclerosis.Multiple sclerosisIRCT2012072110349N1Isfahan University of Medical Sciences10
Completed
Phase 2
The effect of plasma rich in growth factors in treatment of gingival recessioGingival Recession.Gingival recession (generalized)(localized)(post infective)(post-operative)IRCT201201168747N1Vice chancellor for research, Babol University of Medical Sciences22
Recruiting
Not Applicable
The efficacy of cPED for TMAThrombotic microangiopathyJPRN-jRCTs022190024Satoh Kasumi5
Recruiting
Not Applicable
Efficacy and Safety Evaluation According to Plasma Concentration Measurement on Direct Oral Anticoagulation Using Factor-Xa Inhibitors for Non-valvular Atrial Fibrillation on Multicenter Studyon-valvular atrial fibrillationJPRN-UMIN000036769Hokusetsu General Hospital Clinical laboratory division3,000